Astle Christopher bought ZYME
January 5, 2024 · Form 4 insider transaction
Astle Christopher bought 10,500 shares of Zymeworks Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,500
Price
$0.00
Total value
N/A
InsiderAstle Christopher
RoleOfficer
CompanyZymeworks Inc. (ZYME)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 5, 2024
Filing dateJanuary 8, 2024
Shares owned after12,497
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares of common stock issued upon vesting of one third of the restricted stock units ("RSUs") granted on January 5, 2023.